Therapeutic Effects of Switching to Anagliptin from Other DPP-4 Inhibitors in T2DM Patients with Inadequate Glycemic Control: A Non-interventional, Single-Arm, Open-Label, Multicenter Observational Study

INTRODUCTION: The effects of switching DPP-4 inhibitors in type 2 diabetes mellitus (T2DM) patients are being widely studied. However, information of which factors affect the therapeutic response is limited. We evaluated the difference in HbA1c lowering effect by comorbidity and other variables afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sang-Yong, Kim, Sungrae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880082/
https://www.ncbi.nlm.nih.gov/pubmed/36417158
http://dx.doi.org/10.1007/s13300-022-01339-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880082/
https://www.ncbi.nlm.nih.gov/pubmed/36417158
http://dx.doi.org/10.1007/s13300-022-01339-4

Ejemplares similares